| Año publicación | Título | Código | Acrónimo | Tipo | Área | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial. | 24.001 | PREVESTATGx | RESULTADOS | Farmacología | ||||||
| 2020 | Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol | 19.002 | VORIGEPHARM | PROTOCOLO | Farmacología | ||||||
| 2019 | Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains. | 14.013 | AMIKACINA | RESULTADOS | Farmacología |